Medpace Holdings, Inc. (MEDP)
Stock Price:
$124.84 USD
2.82 (2.31%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
4.42B |
| Revenue (ttm) |
882.00M |
| Net Income (ttm) |
106.85M |
| Shares Out |
35.41M |
| EPS (ttm) |
2.83 |
| PE Ratio |
44.11 |
| Forward PE |
31.95 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 7, 2020 |
| Last Price |
$124.84 |
| Previous Close |
$122.02 |
| Change ($) |
2.82 |
| Change (%) |
2.31% |
| Day's Open |
121.79 |
| Day's Range |
121.37 - 125.00 |
| Day's Volume |
225,823 |
| 52-Week Range |
58.72 - 144.49 |
More Stats
| Market Cap |
4.42B |
| Enterprise Value |
4.37B |
| Earnings Date (est) |
Nov 2, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
35.41M |
| Float |
27.35M |
| EPS (basic) |
2.97 |
| EPS (diluted) |
2.83 |
| FCF / Share |
5.31 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
2.27% |
| FCF Yield |
4.25% |
| Payout Ratio |
n/a |
| Shares Short |
2.62M |
| Short Ratio |
10.37 |
| Short % of Float |
24.39% |
| Beta |
1.32 |
| PE Ratio |
44.11 |
| Forward PE |
31.95 |
| P/FCF Ratio |
23.53 |
| PS Ratio |
5.01 |
| PB Ratio |
5.73 |
| Revenue |
882.00M |
| Operating Income |
131.74M |
| Net Income |
106.85M |
| Free Cash Flow |
187.84M |
| Net Cash |
45.92M |
| Net Cash / Share |
1.30 |
| Gross Margin |
61.22% |
| Operating Margin |
14.94% |
| Profit Margin |
12.10% |
| FCF Margin |
21.30% |
| ROA |
7.36% |
| ROE |
15.31% |
| ROIC |
410.90% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (7)
| Buy |
2 |
| Overweight |
0 |
| Hold |
5 |
| Underweight |
0 |
| Sell |
0 |
Analyst Consensus: Overweight
Price Target
$118.40*
(-5.16% downside)
Low
113
Current: $124.84
High
125
Target: 118.40
*Average 12-month price target from 5 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Revenue | 861 | 705 | 436 | 422 | 359 |
| Revenue Growth | 22.19% | 61.55% | 3.46% | 17.41% | - |
| Gross Profit | 246 | 216 | 175 | 172 | 156 |
| Operating Income | 127 | 101 | 64.86 | 52.49 | 20.56 |
| Net Income | 100 | 73.19 | 39.12 | 13.43 | -8.67 |
| Shares Outstanding | 35.88 | 35.55 | 39.06 | 35.69 | 31.35 |
| Earnings Per Share | 2.67 | 1.97 | 0.98 | 0.37 | -0.28 |
| EPS Growth | 35.53% | 101.02% | 164.86% | - | - |
| Operating Cash Flow | 202 | 157 | 97.39 | 91.73 | 85.87 |
| Capital Expenditures | -17.91 | -16.02 | -11.72 | -13.54 | -6.47 |
| Free Cash Flow | 184 | 141 | 85.66 | 78.20 | 79.41 |
| Cash & Equivalents | 132 | 23.28 | 26.49 | 37.41 | 17.74 |
| Total Debt | 45.21 | 79.72 | 222 | 164 | 378 |
| Net Cash / Debt | 86.71 | -56.44 | -195 | -126 | -360 |
| Assets | 1,143 | 968 | 951 | 979 | 984 |
| Liabilities | 417 | 378 | 447 | 368 | 571 |
| Book Value | 726 | 590 | 504 | 611 | 413 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Medpace Holdings, Inc. |
| Country |
United States |
| Employees |
3,400 |
| CEO |
August James Troendle |
Stock Information
| Ticker Symbol |
MEDP |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
NASDAQ: MEDP |
| IPO Date |
August 11, 2016 |
Description
Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is headquartered in Cincinnati, Ohio.